Takeda Pharmaceutical (TAK) EBT Margin (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly EBT Margin of 13.34% for Q2 2026, down 27.0% year-over-year from 18.27% in Q2 2025, and little changed quarter-over-quarter from 13.34% in Q1 2026.
Takeda Pharmaceutical (TAK) EBT Margin (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's EBT Margin history runs 10 years deep, the most recent figure standing at 13.34% for Q2 2026.
- In Q2 2026, EBT Margin fell 27.0% year-over-year to 13.34%; the TTM figure through Jun 2026 stood at 2.63% (down 433.0% YoY), while the FY2026 annual figure was 3.16%, down 698.0% from the prior year.
- EBT Margin for Q2 2026 stood at 13.34%, roughly flat from 13.34% in the prior quarter.
- The five-year high for EBT Margin was 22.93% in Q1 2022, with the low at 41.57% in Q4 2025.
- The 5-year median for EBT Margin is 11.31% (2024), against an average of 7.66%.
- The sharpest annual moves came in 2022 and 2025: EBT Margin jumped 594 bps in 2022, then sank 3139 bps in 2025.
- Takeda Pharmaceutical's EBT Margin stood at 9.77% in 2022, then slumped by 53 bps to 4.56% in 2023, then sank by 323 bps to 10.19% in 2024, then slumped by 308 bps to 41.57% in 2025, then surged by 132 bps to 13.34% in 2026.
- Business Quant data shows TAK's EBT Margin at 13.34% in Q2 2026, 13.34% in Q1 2026, and 41.57% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -0.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.34% |
| Mar 31, 2026 | 13.34% |
| Dec 31, 2025 | -41.57% |
| Sep 30, 2025 | 8.86% |
| Jun 30, 2025 | 13.61% |
| Mar 31, 2025 | 12.47% |
| Dec 31, 2024 | -10.19% |
| Sep 30, 2024 | 8.00% |
| Jun 30, 2024 | 11.31% |
| Mar 31, 2024 | 11.31% |
| Dec 31, 2023 | 4.56% |
| Sep 30, 2023 | 10.18% |
| Jun 30, 2023 | 12.76% |
| Mar 31, 2023 | 14.69% |
| Dec 31, 2022 | 9.77% |
| Sep 30, 2022 | 6.44% |
| Jun 30, 2022 | 15.99% |
| Mar 31, 2022 | 22.93% |
| Dec 31, 2021 | 8.01% |
| Sep 30, 2021 | 7.27% |